David Elías Rabling

David Elías Rabling has a diverse work experience. David has served as the CEO of Birdman (Hombreave SA de CV) since January 2019. Prior to that, they worked as a Business Unit Manager at Pisa Farmacéutica from July 2016 to July 2018, where they played a critical role in developing and executing growth plans. David has also worked as a Business Development Intern at Phynova Group Ltd and as a Business Development External Consultant at Sphere Fluidics Limited in 2015. Additionally, they served as the General Manager and Public Tendering Manager at Grupo Flexipak from 2013 to 2014 and from 2011 to 2014, respectively. David started their career as a Laboratory Intern at Agenolab GmbH in 2011, where they contributed to various research and development projects.

David Elías Rabling completed a Master's in Enterprise degree at the University of Cambridge from 2014 to 2015. Prior to that, they obtained a Bachelor of Science (B.S.) degree in Biotechnology Engineering from Tecnológico de Monterrey. David also holds a certification in Molecular Biology from ITESM Guadalajara Campus. No information is provided regarding the specific date or year of obtaining the certification.